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Background: Some patients under close colonoscopic surveillance still develop colorectal cancer, thus suggesting
the overlook of colorectal adenoma by endoscopists. AFI detects colorectal adenoma as a clear magenta, therefore
the efficacy of AFI is expected to improve the detection ability of colorectal adenoma. The aim of this study is to
determine the efficacy of AFI in detecting colorectal adenoma.
Methods: This study enrolled 88 patients who underwent colonoscopy at Asahikawa Medical University and
Kushiro Medical Association Hospital. A randomly selected colonoscopist first observed the sigmoid colon and
rectum with conventional high resolution endosopy (HRE). Then the colonoscopist changed the mode to AFI and
handed to the scope to another colonoscopist who knew no information about the HRE. Then the second
colonoscopist observed the sigmoid colon and rectum. Each colonoscopist separately recorded the findings. The
detection rate, miss rate and procedural time were assessed in prospective manner.
Results: The detection rate of flat and depressed adenoma, but not elevated adenoma, by AFI is significantly
higher than that by HRE. In less-experienced endoscopists, AFI dramatically increased the detection rate (30.3%) and
reduced miss rate (0%) of colorectal adenoma in comparison to those of HRE (7.7%, 50.0%), but not for experienced
endoscopists. The procedural time of HRE was significantly shorter than that of AFI.
Conclusions: AFI increased the detection rate and reduced the miss rate of flat and depressed adenomas. These
advantages of AFI were limited to less-experienced endoscopists because experienced endoscopists exhibited a
substantially high detection rate for colorectal adenoma with HRE.
Keywords: Autofluorescence imaging, Colorectal adenoma, Detection rate, Flat and depressed adenoma,
Less-experienced endoscopist, High-resolution colonoscopeBackground
Colorectal cancer is one of the most common malignant
tumors in Eastern and Western countries [1]. During the
process of colon carcinogenesis, normal epithelia are
thought to initially turn into benign adenomas, accumu-
late gene alterations and then transform to advanced
adenocarcinomas [2] [3]. All adenoma are considered to* Correspondence: fjym@asahikawa-med.ac.jp
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reproduction in any medium, provided the orbe premalignant lesions. The elimination of colon aden-
oma is therefore an effective strategy to prevent the devel-
opment of colon cancer. Several trials on an endoscopic
resection for colon adenoma successfully decreased the
mortality of colon cancer [4]. However, some patients
under close colonoscopic surveillance still develop colo-
rectal cancer [5]. This discrepancy may be caused by the
rapid progression of adenomas as well as the overlooking
of colorectal adenoma. Indeed, systematic reviews of back-
to back colonoscopies showed that 15% to 32% of colorec-
tal adenomas were possibly missed by colonoscopy [6],
particularly flat and depressed adenomas [7] [8] [9] [10].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the miss rate of adenomas and optimize the potential for
colorectal cancer prevention.
AFI is a novel technology which can capture fluores-
cence (500–630 nm) emitted from intestinal or other tis-
sues. This device produces an excitation light source of
442 nm, delivers it to the tissue surface and then captures
the reflection and fluorescence by two high-sensitivity
CCDs. Those captured signals are respectively trans-
formed into red or blue colors, and then are displayed on
the monitor as a color image in real-time [11] [12]. Fluor-
escence imaging is thought to be an efficient tool for the
evaluation of dysplasia in Barrett esophagus [13] [14] [15],
esophageal and gastric cancer [16] and dysplasia [17] [18]
[19], as well as for making a differential diagnosis of intes-
tinal lymphoma [20] and also for assessing the inflamma-
tion activity in ulcerative colitis [21]. Three studies
proposed the controversial results concerning the useful-
ness of AFI on the detection of colon lesions. Matsuda
et al. proposed the predominance of AFI for detecting
polyps of the proximal colon compared to white light en-
doscopy using a modified back-to-back method [22]. In
contrast, the other two studies showed that AFI did not
reduce the adenoma miss-rate using two inspections of
the entire colon by conventional high-resolution endos-
copy (HRE) or AFI [23] [24]. There seems to be some bias
with regard to these results, since the endoscopic findings
of HRE and AFI could not be assessed independently be-
cause each colonoscopic examination was performed by a
single endoscopist in those studies. Therefore, the efficacyFigure 1 A flow diagram of this study.of AFI in detecting colorectal adenoma still remains to be
elucidated.
The current study aimed to assess the efficacy of AFI
for improving the colorectal adenoma detection rate by
comparing experienced and less experienced endosco-
pists in a prospective manner.
Methods
Patients
This prospective study was registered with University
Hospital Medical Information Network (ID number;
R000002463). Written informed consent was obtained
from all patients enrolled and the study was approved by
the institutional review board of Asahikawa Medical Uni-
versity and Kushiro Medical Association Hospital. Eighty-
eight patients were enrolled in this prospective study. All
patients underwent colonoscopy with an AFI examination
(CF-FH260AZI, Olympus medical systems, Tokyo, Japan)
at Asahikawa Medical University and Kushiro Medical As-
sociation Hospital between January 2008 and December
2008. According to the inclusion criteria, patients who
could understand the background information, aims,
methods and potential adverse effects of participating in
the study were enrolled. The exclusion criteria were an
age younger than 18 years, polyposis syndrome, inflamma-
tory bowel disease, severe coagulopathy, stricture, bleed-
ing, and severe cardiac, pulmonary or renal diseases. A
total of 193 patients were initially eligible for this study,
and 108 of these patients were excluded because they did
not consent to participate. Finally, 88 patients were
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enrolled patients and detected lesions are summarized in
Table 1. The indications for colonoscopy were abdominal
symptoms such as abdominal pain and abnormal
defecation in 28 patients, for screening in 38 patients and
for surveillance in 22 patients. The shape of the lesions
was classified according to the Paris endoscopic classifica-
tion [25].
Colonoscopic instruments
A high definition colonoscope (CF-FH260AZI; Olympus
Inc.) containing 2 CCDs: 1 for HRE/NBI and 1 for AFI,
an Olympus Lucera Spectrum video processor and a
high definition monitor were used for the colonoscopy
studies. AFI uses blue light (390 –470 nm) for excitation
and green light (540–560 nm) is for reflection. A barrier
filter allows passage of light to the charge-coupled
devices with wavelengths between 500 and 630 nm only,
and consisting of autofluorescence emission and green
reflectance. AFI images were diagnosed based on the
predominant color intensity. The normal mucosa and
adenoma appear green and magenta, respectively, by
AFI (Figure 2).
Colonoscopic procedure and randomization
All patients were prepared using 2 L of polyethylene gly-
col solution in this study. None of them exhibited insuf-
ficient bowel preparation. All procedures were
performed by one of either 5 experienced endoscopists
(> 8000 standard and> 100 AFI) or 3 less-experienced
endoscopists (< 500 standard and< 10 AFI). Because
this study aimed to elucidate the differences in the sig-
nificance of AFI between experienced and less-
experienced endoscopists, we selected highly experi-
enced endoscopists and endoscopists with much lessTable 1 Demographics of the patients and detected
lesions
M : F 45 : 43
Mean age (y.o.) 64.0 ± 10.0
Indication for colonoscopy
Indication for colonoscopy (symptoms: screening:
surveillance)
28 : 38 : 22
Number of lesions 88
Adenoma 29
Size (mm) 5.8 ± 6.5
Type 0-IIa 18
Type 0-IIb or 0-IIc 11
Hyperplasia 59
Size (mm) 3.7 ± 1.8
Elevated 13
Flat & depressed 46experience. A colonoscopist who was randomly selected
with a sealed envelope method first observed the sig-
moid colon and rectum (for 40 cm from anal verge) with
HRE. Next, the colonoscopist changed the mode for AFI
and handed to the scope to another colonoscopist who
was not aware of the information of HRE. The second
colonoscopist who was also selected using a sealed enve-
lope method inserted a colonoscope for 40 cm and
observed the sigmoid colon and rectum under sufficient
filling with air. Each colonoscopist separately recorded
the colonoscopic findings including the location, color
and shape of the detected lesions (Figure 1). Thereafter,
both colonoscopists cooperated to insert the scope again
and obtain biopsy specimens from all detected lesions.
The biopsied specimens were histologically diagnosed by
a pathologist with no clinical and endoscopic informa-
tion according to the Vienna classification [26]. The en-
tire procedural time for each procedure was separately
measured and recorded for all the patients. The detected
lesions were classified into two groups, elevated type (0-
IIa) and flat or depressed type (0-IIb or -IIc) according
to Paris classification [25]. The detection rate and miss
rate of colorectal adenoma by all participants, experi-
enced or less-experienced endoscopists were assessed.
The ratio of the cases with adenoma divided by the all
cases enrolled was defined as the detection rate. The
miss rate was defined as the ratio of all detected aden-
oma divided by the adenoma as diagnosed by each pro-
cedure. The primary goal of this study was to determine
the detection ability of AFI in comparison to that of
HRE. The second goal was to explore whether the use-
fulness of AFI for detecting colon lesions was influenced
by the morphological features of colon lesions and the
experience of the endoscopist. These two secondary out-
comes were both exploratory.
Statistical analysis
To determine the sample size, our preliminary data sug-
gested that the miss rates of HRE and AFI for the detec-
tion of colon adenoma were 25.0% and 4.2%,
respectively. When the alpha error was defined as 0.05
(two-sided) and the power as 0.8, the number of cases
required was estimated to be 66 (33 for each group).
Twenty-five percent of the enrolled cases were thought
to drop out of the study, so the target number of cases
was 85. A total of 88 patients were enrolled and analyzed
in this study.
The Wilcoxon signed-rank test was applied for the
statistical analysis of the detection and miss rates, and
for the procedural time in all participants, because the
data were paired and non-parametric. The Mann–Whit-
ney U-test was used to perform the statistical analysis of
such data by either experienced or less-experienced
endoscopists, because the data were unpaired and non-
Figure 2 Cases of flat and depressed adenoma and normal mucosa. A faint red area in the sigmoid colon was noted by HRE (A). AFI
revealed a strong magenta area at the same site (B). In the normal mucosa, HRE showed no abnormal findings (C) and AFI revealed no magenta
area (D).
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tically significant. For the purposes of the statistical ana-
lysis, individual lesions were assumed to constitute
statistically independent observations even when more












All adenoma HRE 88 16 18.2 p< 0.05
AFI 88 23 26.1
Flat and
depressed adenoma
HRE 88 3 3.4 p< 0.05
AFI 88 8 9.1
Elevated adenoma HRE 88 13 14.8 N.S.




HRE 54 14 25.9 N.S.





HRE 34 2 5.9 p< 0.05
AFI 33 10 30.3
N.S.; not significant.Results
The detection rate of colorectal adenoma and procedural
time of HRE and AFI (Table 2).
HRE was performed by experienced endoscopists in 54
of 88 cases and by less-experienced endoscopists in 34
cases. AFI was performed by experienced endoscopists
in 55 cases and by less-experienced endoscopists in 33
cases. In 24 of 88 cases, one or more adenomas, which
were histologically classified into category 3 or 4.1
according to the Vienna classification [26], were detected
by either HRE or AFI. No lesions corresponding to false
positive regions, such as normal mucosa or vascular ab-
normalities, were detected by either HRE or AFI.
Whereas HRE detected one or more colorectal aden-
omas in 16 of 88 cases (18.2%), AFI detected colorectal
adenoma in 23 cases (26.1%). The detection rate for
AFI is therefore significantly higher than that for HRE
(p< 0.05). AFI detected 8 0-IIb or 0-IIc adenomas in 88
cases while conventional colonoscopy detected only 3
(p< 0.05). In contrast, no difference was observed betweenHRE and AFI regarding the detection rate of 0-IIa
adenomas.
AFI dramatically increased the detection rate of colo-
rectal adenoma (30.3%) in comparison to that of HRE
(7.7%; p< 0.05) in less-experienced endoscopists. Con-
versely, the detection rate of HRE in experienced
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that of AFI (23.6%). The procedural time of HRE
(144.5 ± 8.8 seconds) was significantly shorter than that
of AFI in all participants (267.0 ± 20.8 seconds; p< 0.05;
Figure 3A). This increase in the length of time required
to perform the AFI examination was identified for both
experienced endoscopists (Figure 3B) as well as less-
experienced endoscopists (Figure 3C).
The miss rate of colorectal adenoma with HRE and
AFI (Table 3).
Twenty-nine adenomas were detected by either HRE
or AFI in 88 cases. Twenty-one of the 29 adenomas
detected from the 88 patients were captured by HRE
and 28 were captured by AFI. The miss rate of HRE
(27.6%) was significantly higher than that of AFI (3.4%; p
< 0.05). The miss rate of HRE (50.0%) was much higher
than that of AFI (0%) in less-experienced endoscopists
while no significant deference in the miss rate was seen
between HRE (24%) and AFI (5.3%) in experienced
endoscopists, thus suggesting the efficacy of AFI in
detecting colorectal adenoma by less-experienced
endoscopists.
Discussion
The current study demonstrated that AFI improved the
detection rate of colorectal adenoma, particularly flat
and depressed adenomas, but not for elevated adenomas.
An elevated adenoma is easily detected as a reddish and
protruding lesion by HRE because HRE can detects ab-
normalities through capturing the changes of color and
shape. However, flat and depressed adenoma is some-
times described just a faint red areas with no elevation,
which thus tend to be difficult to detect by HRE. On the
other hand, AFI captures the fluorescence mostly emit-
ted from collagen in the submucosal layer and diagnoses
the abnormal area through a diminished fluorescence in-
tensity. The dysplastic grade of the lesions is the mainFigure 3 Procedural time of HRE and AFI. The procedural time of HRE (1
participants (267.0 ± 20.8 seconds; p< 0.05) (A). An increase in the procedu
endoscopists (B) or less-experienced endoscopists (C).factor that affects the fluorescence captured by AFI [27].
The increase in dysplasia appears to facilitate the detec-
tion rate of colorectal adenoma by AFI, regardless the
shape of the lesion.
A noteworthy finding of the current study is that the
efficacy of AFI to detect colorectal adenoma was limited
for less-experienced endoscopists. The experienced
endoscopists appeared to empirically recognize many of
adenomas, even flat and depressed adenoma, with HRE,
and thus AFI was not a superior disgnostic modality for
experienced endoscopists in detecting colorectal aden-
oma. The present study revealed that the miss rate with
HRE by experienced endoscopists (24.0%) is relatively
lower than that previously reported [22] [26] [28] [29]
[30]. This was probably because only highly experienced
endoscopists (> 8000 standard and> 100 AFI) were
strictly selected as experienced endoscopists in this
study. Conversely, it should not be easy for less-
experienced endoscopists to find colorectal adenoma
(50.0%), particularly flat and depressed adenoma, with
HRE. Most endoscopists, including less-experienced
endoscopists, can immediately utilize AFI because AFI
diagnosis is simply based on the color intensity of ma-
genta. This objectivity of AFI probably facilitated the de-
tection rate and reduced the miss rate of colorectal
adenoma in less-experienced endoscopists. The clinical
value of HRE and AFI is therefore considered to depend
on the experience of endoscopists.
Three previous reports have shown controversial
results concerning the efficacy of AFI for detecting colo-
rectal adenoma. Matsuda et al. concluded that AFI
showed a higher detection rate than did white light en-
doscopy when using a modified back to back method
wherein the authors observed the proximal colon twice,
once with white light endoscopy and once with AFI, with
both examinations being performed by the same endos-
copist [22]. Subsequently, two investigations proposed44.5 ± 8.8 seconds) was significantly shorter than that of AFI in all
ral time for the AFI examination was revealed in either experienced
Table 3 The miss rate of colorectal adenoma with HRE and AFI
lesions Procedures Number of lesions detected missed Miss rates (%) p value
All participants Total HRE 88 38 43.2 p< 0.0001
AFI 88 4 4.5
Adenoma HRE 29 8 27.6 p< 0.05
AFI 29 1 3.4
Hyperplasia HRE 59 30 50.8 p< 0.0001
AFI 59 3 5.1
Experienced endoscopists Total HRE 60 23 38.3 p< 0.0001
AFI 62 3 4.8
Adenoma HRE 25 6 24.0 N.S.
AFI 19 1 5.3
Hyperplasia HRE 35 17 48.6 p< 0.0001
AFI 43 2 4.7
Less experienced endoscopists Total HRE 28 15 53.6 p< 0.0001
AFI 26 1 3.8
Adenoma HRE 4 2 50.0 p< 0.05
AFI 10 0 0.0
Hyperplasia HRE 24 13 54.2 p< 0.005
AFI 16 1 6.3
N.S.; not significant.
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method. These studies inspected the entire colon twice
during withdrawal: once with AFI and once with HRE by
the same endoscopist and found no efficiency of AFI for
reducing the adenoma miss-rate in comparison to HRE
[23] [24]. These studies possess a potential bias because
both endoscopic examinations are performed by the
same endoscopist and the second endoscopic diagnosis
was therefore influenced by the findings of the first en-
doscopy. This may explain the controversial results
obtained from the two similar studies. Conversely, in the
current study, AFI was performed by an endoscopist who
was not aware of the information of HRE. This allowed
the determination of the efficiency of AFI in the detec-
tion of flat and depressed adenoma by less-experienced
endoscopists.
Chromoendoscopy can improve the detection of colonic
lesions [31-36]. However, chromoendoscopy with magni-
fied observation is time-consuming, operator-dependent
and impossible to switch back to the conventional col-
onoscopy, which may affect the ability to detect muco-
sal abnormalities in other areas. Narrow band imaging
(NBI), a new system in which spectral features are
modified by narrowing the bandwidth of spectral trans-
mittance with optical filters and can assess capillary
architecture and microvessels just by manipulating a
button [37] [38], is also a promising tool to improve
the detection rate of colorectal adenoma [28] [39]. In-
deed, recent studies have demonstrated adenoma miss-rates for HRE of 40% to 46% when a second examin-
ation was performed with NBI. This suggests that NBI
is superior to HRE when utilized for adenoma detection
[28] [29]. Because NBI has a high ability to discriminate
colon adenoma from hyperplasia [40] [41], the combin-
ation of AFI and NBI can potentially improve the se-
lective detection rate of colon adenoma. Further
analysis to compare the efficacy of AFI, NBI or their
combination for detecting colon neoplasms is therefore
needed to establish the optimal diagnostic modality to
perform screening colonoscopy using new advanced
imaging systems such as NBI and AFI.
The procedural time to perform AFI (267.0 ± 20.8 sec-
onds) was significantly longer than that of HRE
(144.5 ± 8.8 seconds). This is a disadvantage of AFI when
using it as screening examinations. Whereas AFI can
capture the fluorescence emitted from intestinal tissue,
the resolution of AFI is still not sufficient. Therefore,
endoscopists have to be cautious when performing colo-
noscopic examinations with AFI, in order not to increase
the overall examination time. New advances in endo-
scopic tools are expected to produce a higher resolution
and optimized operation system of AFI, thus leading to
a reduction in the time needed to perform the AFI
procedures.
Because it is not easy to judge the lesions detected by
both HRE and AFI, or either of the two procedures (par-
ticularly when multiple lesions are detected), when the
entire colon is targeted, this study investigated only the
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of this study. A further analysis covering the entire colon
will be warranted to draw conclusions about the overall
usefulness of AFI for the detection of colon lesions.
Conclusion
The current study demonstrated that AFI increased the
detection rate and reduced the miss rate of colorectal
adenoma, particularly flat and depressed adenomas.
However, this advantage of AFI was limited to the less-
experienced endoscopists because experienced endosco-
pists exhibited a substantially low miss rate of colorectal
adenoma with HRE. Further advances in endoscopic
instruments will provide an AFI with a high resolution
and optimized operation system, thereby preventing the
lengthy procedural time which is a disadvantage of AFI.
Competing interests
We declare that no authors have any financial relationships with commercial
entities producing health-care related products and/or services relevant to
this article.
Author details
1Division of Gastroenterology and Hematology/Oncology, Department of
Medicine, Asahikawa Medical University, 2-1 Midorigaoka-higashi, Asahikawa,
Hokkaido 078-8510, Japan. 2Internal Medicine, Kotoni Royal Hospital,
2-Nishi1-1-1, Hachiken, Nishi-ku, Sapporo, Hokkaido 063-0842, Japan. 3Internal
Medicine, Kushiro Medical Association Hospital, 4-30 Nusamai-cho, Kushiro,
Hokkaido 085-0836, Japan. 4Division of Upper Gastroenteroelogy,
Department of Internal Medicine, Hyogo College of Medicine, 1-1
Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. 5Digestive Disease
Center, Asahikawa City Hospital, 1-1-65 Kinsei-cho, Asahikawa, Hokkaido
070-8610, Japan.
Author’s contributions
K.M. and M.F. provided major input into the conceptual development of the
studies, wrote the manuscript and supervised all investigations. R.S., J.W., Y.N.,
T.N., N.U., S.K., K.I., Y.I. and H.T. performed the endoscopic examinations. Y.I.
assessed the histological findings. S.M., C.I., T.I. and K.O. managed and treated
the enrolled patients and collected and analyzed the data. Y.M., Y.S. and Y.K.
helped design studies, interpret the data, and prepare/review the
manuscript. All authors read and approved the final manuscript.
Received: 12 October 2011 Accepted: 22 June 2012
Published: 22 June 2012
References
1. Potter JD: Colorectal cancer: molecules and populations. J Natl Cancer Inst
1999, 91:916–932.
2. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis.
Cell 1990, 61:759–767.
3. Lengauer C, Kinzler K, Vogelstein B: Genetic instabilities in human cancers.
Nature 1998, 396:643–649.
4. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, Waye
JD, Schapiro M, Bond JH, Panish JF, Ackroyd F, Shike M, Kurtz RC, Hornsby-
Lewis L, Gerdes H, Stewart ET, National Polyp Study Workgroup: Prevention
of Colorectal Cancer by Colonoscopic Polypectomy. N Eng J Med 1993,
329:1977–1981.
5. Robertson DJ, Greenberg ER, Beach M, Sandler RS, Ahnen D, Haile RW,
Burke CA, Snover DC, Bresalier RS, McKeown-Eyssen G, Mandel JS, Bond JH,
Van Stolk RU, Summers RW, Rothstein R, Church TR, Cole BF, Byers T, Mott L,
Baron JA: Colorectal cancer in patients under close colonoscopic
surveillance. Gastroenterology 2005, 129:34–41.
6. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E:
Polyp miss rate determined by tandem colonoscopy: a systematic
review. Am J Gastroenterol 2006, 101:343–350.7. Fujii T, Rembacken BJ, Dixon MF, Yoshida S, Axon AT: Flat adenomas in the
United Kingdom: are treatable cancers being missed? Endoscopy 1998,
30:437–443.
8. Rembacken BJ, Fujii T, Cairns A, Dixon MF, Yoshida S, Chalmers DM, Axon
AT: Flat and depressed colonic neoplasms: a prospective study of 1000
colonoscopies in the UK. Lancet 2000, 355:1211–1214.
9. Saitoh Y, Waxman I, West AB, Popnikolov NK, Gatalica Z, Watari J, Obara T,
Kohgo Y, Pasricha PJ: Prevalence and distinctive biologic features of flat
colorectal adenomas in a North American population. Gastroenterology
2001, 120:1657–1665.
10. Tsuda S, Veress B, Tóth E, Fork FT: Flat and depressed colorectal tumours
in a southern Swedish population: a prospective chromoendoscopic and
histopathological study. Gut 2002, 51:550–555.
11. Takehana S, Kaneko M, Mizuno H: Endoscopic Diagnostic System Using
Autofluorescence. Diagnostic and Therapeutic Endoscopy 1999, 5:59–63.
12. Namihisa A, Miwa H, Watanabe H, Kobayashi O, Ogihara T, Sato N: A new
technique: light-induced fluorescence endoscopy in combination with
pharmacoendoscopy. Gastrointest Endosc 2001, 53:343–348.
13. Georgakoudi I, Jacobson BC, Van Dam J, Backman V, Wallace MB, Müller MG,
Zhang Q, Badizadegan K, Sun D, Thomas GA, Perelman LT, Feld MS:
Fluorescence, reflectance, and light-scattering spectroscopy for
evaluating dysplasia in patients with Barrett’s esophagus. Gastroenerology
2001, 120:1620–1629.
14. Borovicka J, Fischer J, Neuweiler J, Netzer P, Gschossmann J, Ehmann T,
Bauerfeind P, Dorta G, Zürcher U, Binek J, Meyenberger C: Autofluorescnce
endoscopy in surveillance of Barrett’s esophagus. A multicenter
randomized trial on diagnostic efficacy. Endoscopy 2006, 38:867–872.
15. Kara MA, Bergman JJGH: Autofluorescence imaging and narrow-band
imaging for the detection of early neoplasia inpatients with Barrett’s
esophagus. Endoscopy 2006, 38:627–631.
16. Uedo N, Iishi H, Tatsuta M, Yamada T, Ogiyama H, Imanaka K, Sugimoto N,
Higashino K, Ishihara R, Narahara H, Ishiguro S: A novel videoendoscopy
system by using autofluorescence and reflectance imaging for diagnosis
of esophagogastric cancers. Gastrointest Endosc 2005, 62:521–528.
17. Messmann H, Endlicher E, Freunek G, Rümmele P, Schölmerich J, Knüchel R:
Fluorescence endoscopy for the detection of lowand high grade
dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic
acid sensitization. Gut 2003, 52:1003–1007.
18. Matsumoto T, Moriyama T, Yao T, Mibu R, Iida M: Autofluorescence
imaging colonoscopy for the diagnosis of dysplasia in ulcerative colitis.
Inflamm Bowel Dis 2007, 13:640–641.
19. van den Broek FJ, Fockens P, van Eeden S, Reitsma JB, Hardwick JC,
Stokkers PC, Dekker E: Endoscopic tri-modal imaging for surveillance in
ulcerative colitis: randomised comparison of high-resolution
endoscopy and autofluorescence imaging for neoplasia detection; and
evaluation of narrow-band imaging for classification of lesions. Gut
2008, 57:1083–1089.
20. Ueno N, Fujiya M, Moriichi K, Ikuta K, Nata T, Konno Y, Ishikawa C, Inaba Y,
Ito T, Sato R, Okamoto K, Tanabe H, Maemoto A, Sato K, Watari J, Ashida T,
Saitoh Y, Kohgo Y: Endosopic Autofluorescence Imaging is Useful for the
Differential Diagnosis of Intestinal Lymphomas Resembling Lymphoid
Heyperplasia. J Clin Gastroenterol 2011, 45:507–513.
21. Fujiya M, Saitoh Y, Watari J, Moriichi K, Kohgo Y: Auto-Fluorescence
Imaging is useful to assess the activity of ulcerative colitis. Dig Endosc
2007, 19:145–149.
22. Matsuda T, Saito Y, Fu KI, Uraoka T, Kobayashi N, Nakajima T, Ikehara H,
Mashimo Y, Shimoda T, Murakami Y, Parra-Blanco A, Fujimori T, Saito D:
Does autofluorescence imaging videoendoscopy system improve the
colonoscopic polyp detection rate?—a pilot study. Am J Gastroenterol
2008, 103:1926–1932.
23. van den Broek FJ, Fockens P, Van Eeden S, Kara MA, Hardwick JC, Reitsma
JB, Dekker E: Clinical evaluation of endoscopic trimodal imaging for the
detection and differentiation of colonic polyps. Clin Gastroenterol Hepatol
2009, 7:288–295.
24. Rotondano G, Bianco MA, Sansone S, Prisco A, Meucci C, Garofano ML,
Cipolletta L: Trimodal endoscopic imaging for the detection and
differentiation of colorectal adenomas: a prospective single-centre
clinical evaluation. Int J Colorectal Dis 2012, 27:331–336.
25. Participants in the Paris Workshop. The Paris endoscopic classification of
superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to
December 1, 2002. Gastrointest Endosc 2003, 58:3–43.
Moriichi et al. BMC Gastroenterology 2012, 12:75 Page 8 of 8
http://www.biomedcentral.com/1471-230X/12/7526. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon
MF, Fenoglio-Preiser CM, Fléjou JF, Geboes K, Hattori T, Hirota T, Itabashi M,
Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers
GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M,
Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H: The
Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000,
47:251–255.
27. Moriichi K, Fujiya M, Sato R, Nata T, Nomura Y, Ueno N, Ishikawa C, Inaba Y,
Ito T, Okamoto K, Tanabe H, Mizukami Y, Watari J, Saitoh Y, Kohgo Y:
Autofluorescence imaging and the quantitative intensity of fluorescence
for evaluating the dysplastic grade of colonic neoplasms. Int J Colorectal
Dis 2011, 27:325–330.
28. Rastogi A, Bansal A, Wani S, Callahan P, McGregor DH, Cherian R, Sharma P:
Narrow-band imaging colonoscopy—a pilot feasibility study for the
detection of polyps and correlation of surface patterns with polyp
histologic diagnosis. Gastrointest Endosc 2008, 67:280–286.
29. East JE, Suzuki N, Stavrinidis M, Guenther T, Thomas HJ, Saunders BP:
Narrow band imaging for colonoscopic surveillance in hereditary non-
polyposis colorectal cancer. Gut 2008, 57:65–70.
30. Heresbach D, Barrioz T, Lapalus MG, Coumaros D, Bauret P, Potier P,
Sautereau D, Boustière C, Grimaud JC, Barthélémy C, Sée J, Serraj I, D'Halluin
PN, Branger B, Ponchon T: Miss rate for colorectal neoplastic polyps: a
prospective multicenter study of back-to-back video colonoscopies.
Endoscopy 2008, 40:284–290.
31. Brooker JC, Saunders BP, Shah SG, Thapar CJ, Thomas HJ, Atkin WS,
Cardwell CR: Williams CB; Total colonic dye-spray increases the detection
of diminutive adenomas during routine colonoscopy: a randomized
controlled trial. Gastrointest Endosc 2002, 56:333–338.
32. Hurlstone DP, Cross SS, Slater R, Sanders DS, Brown S: Detecting diminutive
colorectal lesions at colonoscopy: a randomised controlled trial of pan-
colonic versus targeted chromoscopy. Gut 2004, 53:376–380.
33. Lapalus MG, Helbert T, Napoleon B, Rey JF, Houcke P: Ponchon T; Société
Française d'Endoscopie Digestive: Does chromoendoscopy with
structure enhancement improve the colonoscopic adenoma detection
rate?. Endoscopy 2006, 38:444–448.
34. Le Rhun M, Coron E, Parlier D, Nguyen JM, Canard JM, Alamdari A,
Sautereau D, Chaussade S, Galmiche JP: High resolution colonoscopy with
chromoscopy versus standard colonoscopy for the detection of colonic
neoplasia: a randomized study. Clin Gastroenterol Hepatol 2006, 4:349–354.
35. Kato S, Fujii T, Koba I, Sano Y, Fu KI, Parra-Blanco A, Tajiri H, Yoshida S,
Rembacken B: Assessment of colorectal lesions using magnifying
colonoscopy and mucosal dye spraying: can significant lesions be
distinguished? Endoscopy 2001, 33:306–310.
36. Fu KI, Sano Y, Kato S, Fujii T, Nagashima F, Yoshino T, Okuno T, Yoshida S,
Fujimori T: Chromoendoscopy using indigo carmine dye spraying with
magnifying observation is the most reliable method for differential
diagnosis between non-neoplastic and neoplastic colorectal lesions: a
prospective study. Endoscopy 2004, 36:1089–1093.
37. Gono K, Yamazaki K, Doguchi N, Nonami T, Obi T, Yamaguchi M, Ohyama N,
Machida H, Sano Y, Yoshida S, Hamamoto Y, Endo T: Endoscopic observation
of tissue by narrow band illumination. Opt Rev 2003, 10:211–215.
38. Gono K, Obi T, Yamaguchi M, Ohyama N, Machida H, Sano Y, Yoshida S,
Hamamoto Y, Endo T: Appearance of enhanced tissue features in narrow-
band endoscopic imaging. J Biomed Opt 2004, 9:568–577.
39. Inoue T, Murano M, Murano N, Kuramoto T, Kawakami K, Abe Y, Morita E,
Toshina K, Hoshiro H, Egashira Y, Umegaki E, Higuchi K: Comparative study
of conventional colonoscopy and pan-colonic narrow-band imaging
system in the detection of neoplastic colonic polyps: a randomized,
controlled trial. J Gastroenterol 2008, 43:45–50.
40. van den Broek FJ, van Soest EJ, Naber AH, van Oijen AH, Mallant-Hent RCh,
Böhmer CJ, Scholten P, Stokkers PC, Marsman WA, Mathus-Vliegen EM,
Curvers WL, Bergman JJ, van Eeden S, Hardwick JC, Fockens P, Reitsma JB,
Dekker E: Combining autofluorescence imaging and narrow-band
imaging for the differentiation of adenomas from non-neoplastic colonic
polyps among experienced and non-experienced endoscopists. Am J
Gastroenterol 2009, 104:1498–1507.41. Sato R, Fujiya M, Watari J, Ueno N, Moriichi K, Kashima S, Maeda S, Ando K,
Kawabata H, Sugiyama R, Nomura Y, Nata T, Itabashi K, Inaba Y, Okamoto K,
Mizukami Y, Saitoh Y, Kohgo Y: The diagnostic accuracy of high-resolution
endoscopy, autofluorescence imaging and narrow-band imaging for
differentially diagnosing colon adenoma. Endoscopy 2011, 43:862–868.
doi:10.1186/1471-230X-12-75
Cite this article as: Moriichi et al.: Back-to-Back Comparison of Auto-
Fluorescence Imaging (AFI) Versus High Resolution White Light
Colonoscopy for Adenoma Detection. BMC Gastroenterology 2012 12:75.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
